Treating and Managing Patients with Opioid or Other Substance Use Disorders
Substance Use Disorder Training Requirements
Beginning on June 27th, 2023, the Consolidated Appropriations Act of 2023 otherwise known as the Medication Access and Training Expansion (MATE) Act, enacted a new one-time, 8-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners - including physicians, dentists, chiropractors, podiatrists, nurse practitioners, and physician assistants - on treating and managing patients with opioid or other substance use disorders.
Specifically, the law requires that if a prescriber is licensed to dispense controlled substances in schedule II, III, IV, or V, that provider must undergo the eight-hour training requirement. The deadline for satisfying this new training requirement is the date of a practitioner’s next scheduled DEA registration submission—regardless of whether it is an initial registration or a renewal registration—on or after June 27, 2023.
Please note:
- Past DATA-Waived training count towards a DEA registrant’s 8-hour training requirement.
- Relevant training from an accredited group – taken prior to the enactment of this new training obligation – counts towards the 8-hour training requirement. *
Read the Training Letter issued by the DEA Diversion Control Division
On Demand Courses From Baylor College of Medicine
Mastering Pain Relief: Navigating the Maze of Medication Management
Dr. Grant Chen discusses the WHO classification of the different types of physical pain and the different types pharmaceutical of pain management options. He focuses on the use of opioids and clinical considerations for their use in pain management strategies.
1 Video (1hr.), 1.00 AMA PRA Category 1 Credit(s)™.
Opioid Use Disorder Conference 2024
This is ten-part series focuses on the pharmacological, psychotherapeutic treatments of OUD along with overviews of impact on families and children. These learning modules will provide a comprehensive view of how to get patients effective OUD treatments in and out of the medical system and gain confidence on how to initiate and/or maintain treatments for OUD.
These recordings are from the Second Annual Opioid Use Disorder Conference on April 20, 2024.
10 videos (0.50 - 1.00 hr each), 5.50 AMA PRA Category 1 Credit(s)™.
Adolescent Substance Use Disorder: Working Through Co-Occurring Conditions
Dr. Edore Onigu-Otite discusses the development of adolescent substance use disorders (SUD), current epidemiological trends, risk factors and co-occurring conditions in adolescent patients with SUD, and comprehensive treatment approaches.
1 Video (1hr.), 1.00 AMA PRA Category 1 Credit(s)™.
Ketamine: When to Refer and What to Expect
Dr. Neil Puri discusses the epidemiology of depression and suicide, their impact on society, and the history of the use of ketamine and esketamine in treating mood disorders. He reviews both approved on-label and off-label uses of different formulations of these drugs, their adverse effects, and possible future uses of them.
1 Video (1hr.), 1.00 AMA PRA Category 1 Credit(s)™.
Opioid Use Disorder Interactive Modules
These learning module addresses this need from the perspective of emergency room clinicians and provides information on how clinicians may address the substance use epidemic from their roles in the emergency department.
7 interactive modules (0.75 - 1.5 hr each), 8.25 AMA PRA Category 1 Credit(s)™.
Medication Assisted Treatment for Alcohol Use Disorder
In this presentation, Dr. Colleen Keough discusses pharmaceutical treatment options for patients with a substance use disorder, particularly alcohol and opioid use disorders. She focuses on practice recommendations for general internists, and includes resources for screening tools and overdose prevention.
1 Video (1hr.), 1.00 AMA PRA Category 1 Credit(s)™.
Neuromodulation for Cancer Pain and Management of Compression Fractures
In this presentation, Dr. Krishna Shah discusses the potential benefits of the various types of neuromodulation therapy in treating pain caused by chronic compression fractures.
1 Video (1hr.), 1.00 AMA PRA Category 1 Credit(s)™.
A Practical Approach to Cancer Pain Management
In this presentation, Dr. Charu Agrawal and Dr. Paige Farinholt discuss the importance of effective and safe pain management to promote improved patient quality of life.
1 Video (1hr.), 1.00 AMA PRA Category 1 Credit(s)™.
Opioid Use Disorder Conference 2023
This conference addresses the educational gaps of diagnosing opioid use disorder and provide referral and treatment options within the Baylor, Harris Health, and the medical center.
13 Videos (15-45min. ea.), 6.00 AMA PRA Category 1Credit(s)™.
Bringing Alcohol and Other Drug Research to Primary Care
Bringing Alcohol and Other Drug Research to Primary Care is relevant to any healthcare professional that works with patients impacted by substance use. There are 6 self-paced modules that can be completed in any order. You can exit the program at any time, and resume from where you left off.
6 Videos (5-10min. ea.), 1.00 AMA PRA Category 1 Credit(s)™.
Developed by BCM Faculty. You will be directed to an external site.
Background Materials and Additional Courses
Acceptable Sources Include Accredited Courses from the Following:
- The American Society of Addiction Medicine
- The American Academy of Addiction Psychiatry
- The American Medical Association
- The American Osteopathic Association
- The American Dental Association
- The American Association of Oral and Maxillofacial Surgeons
- The American Psychiatric Association
- The American Nurses Credentialing Center
- The American Association of Nurse Practitioners
- The American Academy of Physician Associates
- Any organization approved by the ACCME, or the CCEPR
Pain Management and the Prescription of Opioids
Courses meeting the Texas Medical Board requirement for Pain Management and the Prescription of Opioids for licensure can be counted as described below:
Texas Medical Board recognized AMA credit that meets the Pain Management and the Prescription of Opioids requirement awards topics that relate or focus on inpatient and outpatient treatment of patients with substance use disorders and those requiring pain management because of disease or trauma. Eligible topics include, but are not limited to:
- the efficacy and safety of medications for substance use disorders and acute and chronic pain
- management of acute versus chronic pain
- monitoring of pain management medications in the primary care or inpatient setting
- protocols for the safe and effective management of opioids and other controlled substances
- strategies to improve outcomes of pain management.
Additional Courses
AMA Substance Use Disorders and Addiction Education 57 credit hours available
NIH Training Resources – Alcoholism 10.5 Credit hours available
PCSS – Buprenorphine Training for Physicians 8 Credit hours in variable formats
ACCME - CME Passport Library of Pain Management Over 1500 CME activities available
In selecting courses, you may wish to review the recommendations from SAMHSA - Recommendations for Curricular Elements in Substance Use Disorder Training
- Substance Use Disorders
- Use of validated screening tools for SUD and risk factors for substance use, including mental disorders
- Diagnosis and assessment of individuals who screen positive for SUDs
- The initiation and management of FDA approved medications for SUDs (opioids, alcohol and tobacco), including the impact of unique, individual physiology and metabolism on medication pharmacodynamics
- Consideration of polysubstance use and co-occurring mental disorders
- Patient and family education on safety and overdose prevention (diversion control; safe storage; use of naloxone)
- Effective Treatment Planning
- Use of patient-centered decision making and paradigms of care, and use of evidence-based communication strategies such as shared decision making and motivational interviewing
- The impact of stigma, trauma and the social determinants of health on substance use and recovery
- Collaborating with other disciplines to facilitate access to medications and referrals to services such as case management
- Legal and ethical issues involved in the care of patients with SUD
- Pain management and substance misuse
- The assessment of patients with acute, subacute, or chronic pain
- Components of developing an effective treatment plan, including general principles underlying nonpharmacologic and pharmacologic analgesic therapy, as well as the importance of multidisciplinary treatment interventions
- Managing patients on opioid analgesics, including tapering off the medication when the benefits of opioids no longer outweigh the risks
- Recognizing signs of OUD in the setting of prescribed opioids
*Exceptions to the training requirement:
- Prescribers who are board certified in addiction medicine or addiction psychiatry by the American Board of Medical Specialties, the American Board of Addiction Medicine or the American Osteopathic Association do not need to complete
- A graduate in good standing from a U.S. medical, physician assistant, advanced practice nursing or dental school within five years of June 27, 2023, who successfully completed eight hours of training on treating and managing a patient with opioid and other substance use disorders, including the appropriate clinical use of all drugs approved by the FDA for the treatment of a substance use disorder
Last Reviewed: 05/17/2023